[Efficacy, effectiveness and safety of the adjuvanted influenza vaccine in the population aged 65 or over].

MLA

Arrazola Martínez, M. P., et al. “[Efficacy, Effectiveness and Safety of the Adjuvanted Influenza Vaccine in the Population Aged 65 or Over].” Revista Espanola de Quimioterapia : Publicacion Oficial de La Sociedad Espanola de Quimioterapia, vol. 36, no. 4, Aug. 2023, pp. 334–45. EBSCOhost, https://doi.org/10.37201/req/145.2022.

APA

Arrazola Martínez, M. P., Eiros Bouza, J. M., Plans Rubió, P., Puig-Barberà, J., Ruiz Aragón, J., & Torres Lana, A. J. (2023). [Efficacy, effectiveness and safety of the adjuvanted influenza vaccine in the population aged 65 or over]. Revista Espanola de Quimioterapia : Publicacion Oficial de La Sociedad Espanola de Quimioterapia, 36(4), 334–345. https://doi.org/10.37201/req/145.2022

Chicago

Arrazola Martínez, M P, J M Eiros Bouza, P Plans Rubió, J Puig-Barberà, J Ruiz Aragón, and A J Torres Lana. 2023. “[Efficacy, Effectiveness and Safety of the Adjuvanted Influenza Vaccine in the Population Aged 65 or Over].” Revista Espanola de Quimioterapia : Publicacion Oficial de La Sociedad Espanola de Quimioterapia 36 (4): 334–45. doi:10.37201/req/145.2022.